In an 81‑year‑old patient who reports excessive daytime drowsiness and increased sleep after starting Trintellix (vortioxetine) 5 mg, what management steps should be taken?

Discontinue or reduce Trintellix immediately—it is the likely cause of her worsening daytime drowsiness

The temporal relationship between starting Trintellix 5 mg and the onset of excessive daytime sleepiness strongly suggests drug-induced hypersomnia, which requires prompt medication adjustment to prevent falls, functional decline, and further quality of life deterioration in this elderly patient.

Why Trintellix is the Problem

The FDA label for Trintellix explicitly warns that somnolence is a recognized adverse effect 1. Recent pharmacovigilance data from 2025 confirms somnolence as a significant adverse event with vortioxetine (ROR = 2.0), with most adverse events occurring within the first month of treatment (median onset 15 days) 2. Another 2025 analysis identified somnolence among common adverse events, with 75% of all adverse events occurring within the first month 3.

The American Geriatrics Society guidelines emphasize that in elderly patients with drug-induced sedation, the treatment is to reduce or remove the drug or substance 4. This is particularly critical because:

• Older adults are at greater risk for adverse effects due to reduced drug clearance and increased sensitivity to peak drug effects 4
• Daytime drowsiness is a significant risk factor for falls in elderly patients 4
• Antidepressants, including SSRIs and SNRIs, commonly cause sedation and daytime drowsiness in older adults 4, 5

Immediate Management Steps

1. Medication Adjustment (Primary Action)

• Discontinue Trintellix if depression symptoms are mild or if the patient was started on it for off-label indications
• Reduce to 2.5 mg daily (half the current dose) if continuing treatment is essential for depression management
• The FDA label notes that discontinuation syndrome can occur, so gradual tapering is preferred when stopping 1

2. Assess for Other Contributing Factors

While Trintellix is the most likely culprit given the temporal relationship, evaluate:

• Other sedating medications: Review all medications for anticholinergics, antihistamines, benzodiazepines, or other CNS depressants 4
• Medical conditions: Check for hypothyroidism, hepatic encephalopathy, or neurologic conditions that cause hypersomnia 4
• Sleep apnea: Screen for snoring, witnessed apneas, or morning headaches
• Depression severity: Untreated depression itself causes hypersomnia, but the patient reports worsening after starting medication

3. Monitor for Improvement

• Expect improvement within 1-2 weeks of dose reduction or discontinuation, as most adverse events resolve quickly 3, 2
• Document daytime alertness, functional status, and fall risk
• If no improvement occurs, pursue sleep study or specialist referral

Critical Safety Considerations

Falls Risk: Antidepressants increase fall risk in elderly patients through multiple mechanisms including sedation, orthostatic hypotension, and impaired postural reflexes 5. The combination of advanced age (81 years) and excessive daytime sleepiness creates a dangerous situation requiring urgent intervention.

Cognitive Impact: Excessive daytime sleepiness in elderly patients is associated with cognitive impairment, memory problems, and concentration difficulties 4. Prolonged sedation will worsen quality of life and functional independence.

Alternative Antidepressants: If ongoing antidepressant therapy is needed, consider agents with lower sedation profiles. However, the 2009 NIH guidelines note there is no systematic evidence for effectiveness of many antidepressants in elderly patients, and risks often outweigh benefits 4.

Common Pitfalls to Avoid

• Don't wait to "see if it improves": The patient has already reported worsening symptoms—continued exposure increases fall risk and functional decline
• Don't add stimulants to counteract sedation: This creates polypharmacy and doesn't address the root cause 4
• Don't assume "normal aging": Drug-induced hypersomnia is reversible and should not be accepted as inevitable 4
• Don't abruptly stop without monitoring: Discontinuation syndrome can occur, though it's less severe at lower doses 1